Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

pharmathen s.a. - ibandronska kislina - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - zdravila za zdravljenje bolezni kosti - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. zdravljenje tumorjev-induced hypercalcaemia z ali brez zasevki. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - oftalmologi - eylea je primerna za odrasle, za zdravljenje:neovascular (mokro) starostna degeneracija rumene pege (amd);vida zaradi degeneracija edem sekundarnega do mrežnice vene (veja rvo ali centralne rvo);vida zaradi diabetično degeneracija edem (dme);vida zaradi kratkovidna choroidal neovascularisation (kratkovidna cnv).

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - oftalmologi - zdravilo lucentis je navedeno v odraslih za:zdravljenje neovascular (mokro) starostna degeneracija rumene pege (amd)zdravljenje vida zaradi choroidal neovascularisation (cnv)zdravljenje vida zaradi diabetično degeneracija edem (dme)zdravljenje vida zaradi degeneracija edem sekundarnega do mrežnice vene (veja rvo ali centralne rvo).

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirusi za sistemsko uporabo - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 in 5. tecovirimat siga should be used in accordance with official recommendations.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologi - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

laboratorios liconsa, s.a. - telmisartan - tableta - telmisartan 40 mg / 1 tableta - telmisartan

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

laboratorios liconsa, s.a. - telmisartan - tableta - telmisartan 80 mg / 1 tableta - telmisartan